Yu Yong 4
4 · GENELUX Corp · Filed Aug 29, 2025
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
VP, Clinical Trial Operations
Transactions
- Award
Common Stock
2025-08-27+101,480→ 150,036 total - Award
Stock Option (Right to Buy)
2025-08-27+134,520→ 134,520 totalExercise: $3.64Exp: 2035-08-26→ Common stock (134,520 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter.
- [F2]Includes 916 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan.
- [F3]The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.